| Protein | Synonyms | Taxonomy |
|---|---|---|
| Cytochrome P450 3A4 | EC 1.14.14.1; 1,4-cineole 2-exo-monooxygenase; 1,8-cineole 2-exo-monooxygenase; 1.14.14.56; Albendazole monooxygenase (sulfoxide-forming); 1.14.14.73; Albendazole sulfoxidase; CYPIIIA3; CYPIIIA4; Cholesterol 25-hydroxylase; Cytochrome P450 3A3; Cytochrome | Homo sapiens (human) |
| Cytochrome P450 2C9 | EC 1.14.14.1; (R)-limonene 6-monooxygenase; 1.14.14.53; (S)-limonene 6-monooxygenase; 1.14.14.51; (S)-limonene 7-monooxygenase; 1.14.14.52; CYPIIC9; Cholesterol 25-hydroxylase; Cytochrome P-450MP; Cytochrome P450 MP-4; Cytochrome P450 MP-8; Cytochrome P45 | Homo sapiens (human) |
| Cytochrome P450 2B6 | EC 1.14.13.-; 1,4-cineole 2-exo-monooxygenase; CYPIIB6; Cytochrome P450 IIB1 | Homo sapiens (human) |
| Cytochrome P450 2D6 | Homo sapiens (human) |
| Compound | Description |
|---|---|
| o-demethylmetoprolol | pharmacologically active urinary metoprolol metabolite 5 to 10X less potent than metoprolol; structure in first source; RN given refers to cpd without isomeric designation |
| alpha-hydroxymetoprolol | pharmacologically active urinary metoprolol metabolite 5 to 10X less potent than metoprolol; cpd is alpha-hydroxymetoprolol; structure in first source |
| H117-04 | pharmacologically inactive urinary metoprolol metabolite; structure in first source |